Sinovac Biotech (北京科兴生物制品有限公司) has been selected by the Public Health Bureau of Beijing to be one of four vaccine companies that will supply the city with seasonal flu vaccine for 2009. Sinovac will provide Beijing with its split viron vaccine, Anflu®. The city hopes the vaccine’s usefulness will spread beyond the seasonal flu to also protect its citizens from H1N1 swine flu. Sinovac did not disclose financial terms or its share of the contract. More details...

Stock Symbol: (NYSE: SVA)